Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Amortizatization of Intangibles: 2023-2025

Historic Amortizatization of Intangibles for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to $133,000.

  • Mereo BioPharma Group's Amortizatization of Intangibles rose 3.10% to $133,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $521,000, marking a year-over-year increase of 3.17%. This contributed to the annual value of $507,000 for FY2024, which is 2.42% up from last year.
  • As of Q3 2025, Mereo BioPharma Group's Amortizatization of Intangibles stood at $133,000, which was down 2.21% from $136,000 recorded in Q2 2025.
  • Over the past 5 years, Mereo BioPharma Group's Amortizatization of Intangibles peaked at $136,000 during Q2 2025, and registered a low of $121,000 during Q1 2023.
  • Its 3-year average for Amortizatization of Intangibles is $127,000, with a median of $126,000 in 2025.
  • Data for Mereo BioPharma Group's Amortizatization of Intangibles shows a peak YoY rose of 7.94% (in 2025) over the last 5 years.
  • Mereo BioPharma Group's Amortizatization of Intangibles (Quarterly) stood at $124,000 in 2023, then increased by 1.61% to $126,000 in 2024, then grew by 3.10% to $133,000 in 2025.
  • Its last three reported values are $133,000 in Q3 2025, $136,000 for Q2 2025, and $126,000 during Q1 2025.